LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹93 Cr | ₹73 Cr | ₹69 Cr | ₹62 Cr | ₹51 Cr |
What is the latest Consolidated Net Profit of LINCOLN PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹93 Cr |
Mar2023 | ₹73 Cr |
Mar2022 | ₹69 Cr |
Mar2021 | ₹62 Cr |
Mar2020 | ₹51 Cr |
How is Consolidated Net Profit of LINCOLN PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹93 Cr | 27.99 | |
Mar2023 | ₹73 Cr | 5.11 | |
Mar2022 | ₹69 Cr | 11.41 | |
Mar2021 | ₹62 Cr | 21.02 | |
Mar2020 | ₹51 Cr | - |
Compare Consolidated Net Profit of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,093.4 Cr | -0.2% | -4.5% | -6.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,865.0 Cr | -0.5% | -8.4% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,574.0 Cr | -2.4% | 7.2% | 50.6% | Stock Analytics | |
CIPLA | ₹118,710.0 Cr | -0.7% | -3.7% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,964.0 Cr | -1.4% | -3.9% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,232.0 Cr | 0.5% | 5.6% | 5.1% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -0.2% |
-4.5% |
-6.6% |
SENSEX | -1% |
1.4% |
7.9% |
You may also like the below Video Courses